
Suzanne E. Ziska
Examiner (ID: 13967, Phone: (571)272-8997 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1633, 1806, 1619, 2899, 1804, 1614, 1632 |
| Total Applications | 958 |
| Issued Applications | 443 |
| Pending Applications | 48 |
| Abandoned Applications | 468 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8495517
[patent_doc_number] => 20120294925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'BIOMATERIAL'
[patent_app_type] => utility
[patent_app_number] => 13/482640
[patent_app_country] => US
[patent_app_date] => 2012-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21449
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13482640
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/482640 | BIOMATERIAL | May 28, 2012 | Abandoned |
Array
(
[id] => 8495527
[patent_doc_number] => 20120294935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'PROCESS FOR THE PRECIPITATION AND ISOLATION OF 6,6-DIMETHYL-3-AZA-BICYCLO [3.1.0] HEXANE-AMIDE COMPOUNDS BY CONTROLLED PRECIPITATION AND PHARMACEUTICAL FORMULATIONS CONTAINING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/481098
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33714
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13481098
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/481098 | PROCESS FOR THE PRECIPITATION AND ISOLATION OF 6,6-DIMETHYL-3-AZA-BICYCLO [3.1.0] HEXANE-AMIDE COMPOUNDS BY CONTROLLED PRECIPITATION AND PHARMACEUTICAL FORMULATIONS CONTAINING SAME | May 24, 2012 | Abandoned |
Array
(
[id] => 9574620
[patent_doc_number] => 08765030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-01
[patent_title] => 'Preparation of an enteric release system'
[patent_app_type] => utility
[patent_app_number] => 13/475645
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 5314
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475645
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/475645 | Preparation of an enteric release system | May 17, 2012 | Issued |
Array
(
[id] => 11893966
[patent_doc_number] => 09763884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Drug delivery system'
[patent_app_type] => utility
[patent_app_number] => 14/117619
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 24989
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117619
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117619 | Drug delivery system | May 13, 2012 | Issued |
Array
(
[id] => 10548658
[patent_doc_number] => 09273272
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Natural antimicrobial compositions'
[patent_app_type] => utility
[patent_app_number] => 13/463739
[patent_app_country] => US
[patent_app_date] => 2012-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4263
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463739
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/463739 | Natural antimicrobial compositions | May 2, 2012 | Issued |
Array
(
[id] => 9294123
[patent_doc_number] => 20140037757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS'
[patent_app_type] => utility
[patent_app_number] => 14/112678
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12843
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112678
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112678 | Drug therapy to inhibit chemotherapy-induced adverse effects and related pharmaceutical compositions, diagnostics, screening techniques and kits | Apr 26, 2012 | Issued |
Array
(
[id] => 9756342
[patent_doc_number] => 20140287043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/112769
[patent_app_country] => US
[patent_app_date] => 2012-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 39354
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112769
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112769 | COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS | Apr 22, 2012 | Abandoned |
Array
(
[id] => 8442679
[patent_doc_number] => 20120259294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'METHOD FOR PRODUCTION OF ELECTRO-SPUN TUBULAR ANASTOMOSIS/REVASCULARIZATION DEVICE FOR TREATMENT OF ISCHEMIC TISSUE'
[patent_app_type] => utility
[patent_app_number] => 13/442129
[patent_app_country] => US
[patent_app_date] => 2012-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 939
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13442129
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/442129 | METHOD FOR PRODUCTION OF ELECTRO-SPUN TUBULAR ANASTOMOSIS/REVASCULARIZATION DEVICE FOR TREATMENT OF ISCHEMIC TISSUE | Apr 8, 2012 | Abandoned |
Array
(
[id] => 9222529
[patent_doc_number] => 20140017304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'METHOD FOR ENCAPSULATED THERAPEUTIC PRODUCTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/008290
[patent_app_country] => US
[patent_app_date] => 2012-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6851
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008290
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008290 | METHOD FOR ENCAPSULATED THERAPEUTIC PRODUCTS AND USES THEREOF | Mar 6, 2012 | Abandoned |
Array
(
[id] => 10540681
[patent_doc_number] => 09265785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-23
[patent_title] => 'Compositions comprising decitabine and tetrahydrouridine and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/414546
[patent_app_country] => US
[patent_app_date] => 2012-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 36
[patent_no_of_words] => 23383
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13414546
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/414546 | Compositions comprising decitabine and tetrahydrouridine and uses thereof | Mar 6, 2012 | Issued |
Array
(
[id] => 10191865
[patent_doc_number] => 09220759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-29
[patent_title] => 'Treatment of diabetic patients with a drug eluting stent and adjunctive therapy'
[patent_app_type] => utility
[patent_app_number] => 13/403709
[patent_app_country] => US
[patent_app_date] => 2012-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 14379
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13403709
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/403709 | Treatment of diabetic patients with a drug eluting stent and adjunctive therapy | Feb 22, 2012 | Issued |
Array
(
[id] => 9541880
[patent_doc_number] => 20140166527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'Inhalation Anesthetic Product'
[patent_app_type] => utility
[patent_app_number] => 14/001069
[patent_app_country] => US
[patent_app_date] => 2012-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5213
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001069
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/001069 | Inhalation Anesthetic Product | Feb 22, 2012 | Abandoned |
Array
(
[id] => 8175051
[patent_doc_number] => 20120109300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'SKIN SUBSTITUTE MEMBRANE, MOLD, AND METHOD OF EVALUATING EXTERNAL PREPARATION FOR SKIN'
[patent_app_type] => utility
[patent_app_number] => 13/347203
[patent_app_country] => US
[patent_app_date] => 2012-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10054
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20120109300.pdf
[firstpage_image] =>[orig_patent_app_number] => 13347203
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/347203 | Skin substitute membrane, mold, and method of evaluating external preparation for skin | Jan 9, 2012 | Issued |
Array
(
[id] => 8056991
[patent_doc_number] => 20120078229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'IN VIVO BIOREACTORS AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/310655
[patent_app_country] => US
[patent_app_date] => 2011-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12595
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20120078229.pdf
[firstpage_image] =>[orig_patent_app_number] => 13310655
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/310655 | IN VIVO BIOREACTORS AND METHODS OF MAKING AND USING SAME | Dec 1, 2011 | Abandoned |
Array
(
[id] => 9173994
[patent_doc_number] => 20130315979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'Glucan Gels'
[patent_app_type] => utility
[patent_app_number] => 13/989594
[patent_app_country] => US
[patent_app_date] => 2011-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11933
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989594
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/989594 | Glucan gels | Nov 28, 2011 | Issued |
Array
(
[id] => 10265956
[patent_doc_number] => 20150150953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'PHARMACEUTICAL COMPOSITION ADAPTED FOR ORAL ADMINISTRATION AND THE PROCESS FOR ITS PREPARATION, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, BASED ON AN INTESTINAL MOTILITY MODIFIER AND a-D-GALACTOSIDASE'
[patent_app_type] => utility
[patent_app_number] => 13/885629
[patent_app_country] => US
[patent_app_date] => 2011-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3565
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885629
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/885629 | PHARMACEUTICAL COMPOSITION ADAPTED FOR ORAL ADMINISTRATION AND THE PROCESS FOR ITS PREPARATION, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, BASED ON AN INTESTINAL MOTILITY MODIFIER AND a-D-GALACTOSIDASE | Nov 14, 2011 | Abandoned |
Array
(
[id] => 8158444
[patent_doc_number] => 20120100149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent'
[patent_app_type] => utility
[patent_app_number] => 13/282416
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5090
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20120100149.pdf
[firstpage_image] =>[orig_patent_app_number] => 13282416
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/282416 | Injectable, non-aqueous suspension with high concentration of therapeutic agent | Oct 25, 2011 | Issued |
Array
(
[id] => 7766322
[patent_doc_number] => 20120034279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'TRANSSCLERAL DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/279179
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18292
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034279.pdf
[firstpage_image] =>[orig_patent_app_number] => 13279179
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/279179 | TRANSSCLERAL DELIVERY | Oct 20, 2011 | Abandoned |
Array
(
[id] => 9676352
[patent_doc_number] => 08815260
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-08-26
[patent_title] => 'Treatment of restenosis and stenosis with dasatinib'
[patent_app_type] => utility
[patent_app_number] => 13/273731
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 9693
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13273731
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/273731 | Treatment of restenosis and stenosis with dasatinib | Oct 13, 2011 | Issued |
Array
(
[id] => 8342408
[patent_doc_number] => 08244344
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-14
[patent_title] => 'Drug releasing coatings for medical devices'
[patent_app_type] => utility
[patent_app_number] => 13/272432
[patent_app_country] => US
[patent_app_date] => 2011-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 33864
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13272432
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/272432 | Drug releasing coatings for medical devices | Oct 12, 2011 | Issued |